[Articles] Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study

The DMGN is a reliable prognostic tool for distant metastasis in patients with locoregionally advanced nasopharyngeal carcinoma and might be able to predict which patients benefit from concurrent chemotherapy. It has the potential to guide treatment decisions for patients at different risk of distant metastasis.

Source: The Lancet Oncology - February 7, 2018 Category: Cancer & Oncology Authors: Xin-Ran Tang, Ying-Qin Li, Shao-Bo Liang, Wei Jiang, Fang Liu, Wen-Xiu Ge, Ling-Long Tang, Yan-Ping Mao, Qing-Mei He, Xiao-Jing Yang, Yuan Zhang, Xin Wen, Jian Zhang, Ya-Qin Wang, Pan-Pan Zhang, Ying Sun, Jing-Ping Yun, Jing Zeng, Li Li, Li-Zhi Liu, Na Li Tags: Articles Source Type: research